vs
Doximity, Inc.（DOCS）与Orion Group Holdings Inc（ORN）财务数据对比。点击上方公司名可切换其他公司
Orion Group Holdings Inc的季度营收约是Doximity, Inc.的1.2倍（$216.3M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs 2.2%，领先31.1%），Orion Group Holdings Inc同比增速更快（14.6% vs 9.8%），过去两年Doximity, Inc.的营收复合增速更高（25.2% vs 6.1%）
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
奥里昂集团是源自芬兰的全球化制药企业，1917年成立，总部位于芬兰埃斯波。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分，旗下全部生产基地与大部分研发部门均设立在芬兰。
DOCS vs ORN — 直观对比
营收规模更大
ORN
是对方的1.2倍
$185.1M
营收增速更快
ORN
高出4.9%
9.8%
净利率更高
DOCS
高出31.1%
2.2%
两年增速更快
DOCS
近两年复合增速
6.1%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $216.3M |
| 净利润 | $61.6M | $4.7M |
| 毛利率 | 89.9% | 12.0% |
| 营业利润率 | 38.9% | — |
| 净利率 | 33.3% | 2.2% |
| 营收同比 | 9.8% | 14.6% |
| 净利润同比 | -18.1% | 435.7% |
| 每股收益（稀释后） | $0.31 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCSORN
| Q1 26 | — | $216.3M | ||
| Q4 25 | $185.1M | $233.2M | ||
| Q3 25 | $168.5M | $225.1M | ||
| Q2 25 | $145.9M | $205.3M | ||
| Q1 25 | $138.3M | $188.7M | ||
| Q4 24 | $168.6M | $216.9M | ||
| Q3 24 | $136.8M | $226.7M | ||
| Q2 24 | $126.7M | $192.2M |
净利润DOCSORN
| Q1 26 | — | $4.7M | ||
| Q4 25 | $61.6M | $-240.0K | ||
| Q3 25 | $62.1M | $3.3M | ||
| Q2 25 | $53.3M | $841.0K | ||
| Q1 25 | $62.5M | $-1.4M | ||
| Q4 24 | $75.2M | $6.8M | ||
| Q3 24 | $44.2M | $4.3M | ||
| Q2 24 | $41.4M | $-6.6M |
毛利率DOCSORN
| Q1 26 | — | 12.0% | ||
| Q4 25 | 89.9% | 11.6% | ||
| Q3 25 | 90.3% | 13.2% | ||
| Q2 25 | 89.2% | 12.6% | ||
| Q1 25 | 89.5% | 12.2% | ||
| Q4 24 | 91.6% | 14.0% | ||
| Q3 24 | 90.0% | 11.9% | ||
| Q2 24 | 89.3% | 9.5% |
营业利润率DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | 38.9% | 2.2% | ||
| Q3 25 | 37.8% | 2.4% | ||
| Q2 25 | 37.4% | 1.7% | ||
| Q1 25 | 35.2% | 0.4% | ||
| Q4 24 | 47.4% | 4.4% | ||
| Q3 24 | 38.8% | 3.4% | ||
| Q2 24 | 36.4% | -1.4% |
净利率DOCSORN
| Q1 26 | — | 2.2% | ||
| Q4 25 | 33.3% | -0.1% | ||
| Q3 25 | 36.8% | 1.5% | ||
| Q2 25 | 36.5% | 0.4% | ||
| Q1 25 | 45.2% | -0.7% | ||
| Q4 24 | 44.6% | 3.1% | ||
| Q3 24 | 32.3% | 1.9% | ||
| Q2 24 | 32.7% | -3.4% |
每股收益（稀释后）DOCSORN
| Q1 26 | — | $0.12 | ||
| Q4 25 | $0.31 | $-0.00 | ||
| Q3 25 | $0.31 | $0.08 | ||
| Q2 25 | $0.27 | $0.02 | ||
| Q1 25 | $0.31 | $-0.04 | ||
| Q4 24 | $0.37 | $0.22 | ||
| Q3 24 | $0.22 | $0.12 | ||
| Q2 24 | $0.21 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $6.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $979.3M | $166.7M |
| 总资产 | $1.2B | $478.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCSORN
| Q1 26 | — | $6.3M | ||
| Q4 25 | $64.8M | $1.6M | ||
| Q3 25 | $169.2M | $4.9M | ||
| Q2 25 | $137.3M | $1.7M | ||
| Q1 25 | $209.6M | $13.0M | ||
| Q4 24 | $165.3M | $28.3M | ||
| Q3 24 | $184.2M | $28.3M | ||
| Q2 24 | $111.4M | $4.8M |
总债务DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $23.3M | ||
| Q4 24 | — | $23.2M | ||
| Q3 24 | — | $28.0M | ||
| Q2 24 | — | $60.3M |
股东权益DOCSORN
| Q1 26 | — | $166.7M | ||
| Q4 25 | $979.3M | $159.0M | ||
| Q3 25 | $1.1B | $157.9M | ||
| Q2 25 | $1.0B | $153.2M | ||
| Q1 25 | $1.1B | $150.8M | ||
| Q4 24 | $1.0B | $150.7M | ||
| Q3 24 | $961.2M | $142.4M | ||
| Q2 24 | $913.6M | $111.1M |
总资产DOCSORN
| Q1 26 | — | $478.7M | ||
| Q4 25 | $1.2B | $414.7M | ||
| Q3 25 | $1.3B | $422.4M | ||
| Q2 25 | $1.2B | $432.7M | ||
| Q1 25 | $1.3B | $416.3M | ||
| Q4 24 | $1.2B | $417.3M | ||
| Q3 24 | $1.1B | $430.3M | ||
| Q2 24 | $1.1B | $414.0M |
负债/权益比DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | $60.9M | $13.8M | ||
| Q3 25 | $93.9M | $23.3M | ||
| Q2 25 | $62.1M | $-5.6M | ||
| Q1 25 | $98.5M | $-3.4M | ||
| Q4 24 | $65.2M | $13.4M | ||
| Q3 24 | $68.3M | $37.5M | ||
| Q2 24 | $41.2M | $-15.3M |
自由现金流DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | — | $454.0K | ||
| Q3 25 | — | $13.9M | ||
| Q2 25 | — | $-12.7M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $9.9M | ||
| Q3 24 | — | $33.3M | ||
| Q2 24 | — | $-20.0M |
自由现金流率DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | -6.2% | ||
| Q1 25 | — | -6.6% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 14.7% | ||
| Q2 24 | — | -10.4% |
资本支出强度DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | 0.0% | 4.8% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.0% | 1.8% | ||
| Q2 24 | 0.0% | 2.4% |
现金转化率DOCSORN
| Q1 26 | — | — | ||
| Q4 25 | 0.99× | — | ||
| Q3 25 | 1.51× | 7.05× | ||
| Q2 25 | 1.16× | -6.61× | ||
| Q1 25 | 1.58× | — | ||
| Q4 24 | 0.87× | 1.98× | ||
| Q3 24 | 1.55× | 8.79× | ||
| Q2 24 | 1.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
ORN
暂无分部数据
